bioRxivMicrobiologyPreprint
Increased Epstein-Barr virus C-promoter activity with CTCF-binding site deletion is associated with elevated EBNA2 recruitment.
Abstract
The regulation of transcription from Epstein-Barr virus promoters is known to involve the association of the host CCCTC-binding factor (CTCF) protein. This control involves direct binding of CTCF across the EBV genome and the formation of three-dimensional loops between virus promoters and enhancers. We sought to address how the deletion of a CTCF binding site upstream of the C-promoter (Cp) affected viral transcription in infected lymphoblastoid cell lines (LCLs) and how binding of the EBV trans-activating protein EBNA2 was changed across this promoter. Transcript level from Cp was up-regulated with CTCF binding site deletion, and transcription from other promoters (Wp and Qp) was decreased, while transcript levels were largely unchanged by independent mutation of a Cp-RBPJ{kappa} binding site. In turn, expression of EBNA2 protein was also increased, likely driven by increases in polycistronic EBNA2-encoding transcripts. Finally, Cp up-regulation was associated with an 8-fold increase in EBNA2 enrichment across Cp, concomitant with increased association of the associated cellular factor RBPJ{kappa}, probably due to a more accessible three-dimensional chromatin conformation upstream of Cp. Overall, the data presented here confirm that binding of CTCF directly upstream of Cp is important for the regulation of transcription from this and other EBV promoters.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: gene regulatory network inference
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reactivation of Epstein Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites On The Viral Genome
L. E. M. Dunn, F. Lu, … J. D. Baines·bioRxiv·Nov 1, 2021
- Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naive B cells, and facilitates recruitment of transcription factors to the viral genome.
A. Szymula, R. D. Palermo, … R. E. White·bioRxiv·Aug 22, 2017
- Proteomic Screening Identifies HNRNPA2B1 as an Epigenetic Repressor of Epstein-Barr Virus Reactivation
Febri Gunawan Sugiokto, Y Liu, Renfeng Li·Journal of VirologyPeer-reviewed·Jun 12, 2026
- c-Myc Represses Transcription of the Epstein-Barr Virus Latent Membrane Protein 1 Early After Primary B Cell Infection
A. M. Price, J. E. Messinger, M. Luftig·bioRxiv·Jul 26, 2017
- The CCCTC-binding factor CTCF represses hepatitis B virus Enhancer I and regulates viral transcription
V. D'Arienzo, J. Ferguson, … J. L. Parish·Cellular MicrobiologyPeer-reviewed·Oct 16, 2020
- Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts B cell growth
R. Ponnusamy, R. Khatri, … M. J. West·bioRxiv·Nov 7, 2018